Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100T3FG
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 114
MetricValuePeriodScopeSource row
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31dCons.Net assets
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31Cons.Number of employees
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2023-12-31109 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,272
ItemContextValueUnit
Non audit fees total network firmsCurrentYearDuration3190000JPY
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember71082000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember40710000JPY
Share option remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember30372000JPY
Bonus remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember1
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Share option remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Bonus remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsMember59333000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_OutsideDirectorsMember50074000JPY
Share option remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsMember9259000JPY
Bonus remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsMember6
Cash and depositsPrior1YearInstant6282554000JPY
Cash and depositsCurrentYearInstant6517007000JPY
Accounts receivable tradePrior1YearInstant2084915000JPY
Accounts receivable tradeCurrentYearInstant913094000JPY
Merchandise and finished goodsPrior1YearInstant293757000JPY
Merchandise and finished goodsCurrentYearInstant231650000JPY
Semi finished goodsPrior1YearInstant175170000JPY
Semi finished goodsCurrentYearInstant－JPY
SuppliesPrior1YearInstant452000JPY
SuppliesCurrentYearInstant380000JPY
Advance payments tradePrior1YearInstant252745000JPY
Advance payments tradeCurrentYearInstant271516000JPY
Prepaid expensesPrior1YearInstant209886000JPY
Prepaid expensesCurrentYearInstant119271000JPY
Other caPrior1YearInstant13224000JPY
Other caCurrentYearInstant29607000JPY
Current assetsPrior1YearInstant9312706000JPY
Current assetsCurrentYearInstant8082526000JPY
BuildingsPrior1YearInstant64931000JPY
BuildingsCurrentYearInstant237233000JPY
Accumulated depreciation buildingsPrior1YearInstant-24260000JPY
Accumulated depreciation buildingsCurrentYearInstant-237233000JPY
Buildings netPrior1YearInstant40670000JPY
Buildings netCurrentYearInstant－JPY
Tools furniture and fixturesPrior1YearInstant73159000JPY
Tools furniture and fixturesCurrentYearInstant105107000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant-44819000JPY
Accumulated depreciation tools furniture and fixturesCurrentYearInstant-105107000JPY
Tools furniture and fixtures netPrior1YearInstant28339000JPY
Tools furniture and fixtures netCurrentYearInstant－JPY
Property plant and equipmentPrior1YearInstant69009000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass